,Tumor State,Gene Signature,MWU-BH p-value,MWU-BH-LOOCV p-value,GLM p-value,GLM-LOOCV p-value,Pseudobulk p-value,Pseudobulk-LOOCV p-value
1,Tumor State 1,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.0993,0.1381
2,Tumor State 1,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0,0.0993,0.1381
4,Tumor State 1,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.1955,0.1832
5,Tumor State 1,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0,0.0,0.2957,0.2981
6,Tumor State 1,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.1943,0.2024
7,Tumor State 1,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0,0.0,0.0,0.0,0.3002,0.3014
8,Tumor State 1,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0,0.0,0.0,0.0,0.3008,0.3088
9,Tumor State 1,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0,0.0,0.0,0.0,0.1979,0.2145
10,Tumor State 1,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0,0.0,0.0,0.1408,0.1439
11,Tumor State 1,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.1568,0.1623
13,Tumor State 1,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0,0.0,0.0,0.0993,0.1439
15,Tumor State 1,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.0993,0.1439
16,Tumor State 1,WP_TYPE_III_INTERFERON_SIGNALING,0.0305,0.03,0.0512,0.0569,0.3008,0.3243
17,Tumor State 1,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0,0.0,0.2459,0.2651
18,Tumor State 1,ZHANG_INTERFERON_RESPONSE,0.0,0.0,0.0,0.0,0.3008,0.3243
19,Tumor State 1,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0,0.0,0.0,0.409,0.4303
20,Tumor State 1,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0,0.0,0.0,0.0,0.221,0.2256
21,Tumor State 1,PAM50,0.0,0.0,0.0,0.0,0.409,0.4048
22,Tumor State 1,WU_ET_AL_BASAL_SC,0.0,0.0,0.0,0.0,0.0782,0.0944
23,Tumor State 1,WU_ET_AL_HER2E_SC,0.0,0.0,0.0,0.0,0.0993,0.1342
24,Tumor State 1,WU_ET_AL_LUMA_SC,0.0,0.0,0.0,0.0,0.3008,0.3014
25,Tumor State 1,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.0993,0.0972
26,Tumor State 1,HALLMARK_ADIPOGENESIS,0.0003,0.0005,0.0026,0.0042,0.283,0.2954
27,Tumor State 1,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.0607,0.0678
28,Tumor State 1,HALLMARK_ANDROGEN_RESPONSE,0.0892,0.06,0.0369,0.0225,0.2664,0.2732
29,Tumor State 1,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0,0.0,0.4218,0.4286
30,Tumor State 1,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.1375,0.1475
31,Tumor State 1,HALLMARK_APICAL_SURFACE,0.0,0.0,0.0,0.0,0.1694,0.1908
32,Tumor State 1,HALLMARK_APOPTOSIS,0.0,0.0,0.0002,0.0002,0.4892,0.4702
33,Tumor State 1,HALLMARK_BILE_ACID_METABOLISM,0.015,0.0161,0.0212,0.0245,0.4837,0.483
34,Tumor State 1,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0,0.0,0.0,0.0,0.1171,0.1295
35,Tumor State 1,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0,0.1451,0.1617
36,Tumor State 1,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.134,0.1269
37,Tumor State 1,HALLMARK_DNA_REPAIR,0.0,0.0,0.0001,0.0001,0.2909,0.3
38,Tumor State 1,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.1375,0.1564
39,Tumor State 1,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.4332,0.4442
40,Tumor State 1,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0,0.0,0.0,0.0,0.0642,0.0723
41,Tumor State 1,HALLMARK_ESTROGEN_RESPONSE_LATE,0.0,0.0,0.0,0.0,0.1768,0.1949
42,Tumor State 1,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.4103,0.3847
43,Tumor State 1,HALLMARK_G2M_CHECKPOINT,0.0,0.0,0.0,0.0,0.1375,0.1561
44,Tumor State 1,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.1451,0.1684
45,Tumor State 1,HALLMARK_HEDGEHOG_SIGNALING,0.0002,0.0001,0.0015,0.0009,0.209,0.216
47,Tumor State 1,HALLMARK_HYPOXIA,0.0,0.0,0.0,0.0,0.1527,0.1763
48,Tumor State 1,HALLMARK_IL2_STAT5_SIGNALING,0.0,0.0,0.0,0.0,0.0934,0.1052
49,Tumor State 1,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.0999,0.1103
50,Tumor State 1,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.2472,0.2376
51,Tumor State 1,HALLMARK_KRAS_SIGNALING_DN,0.0,0.0,0.0,0.0,0.4837,0.4681
52,Tumor State 1,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.0607,0.0637
53,Tumor State 1,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.1375,0.158
54,Tumor State 1,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.0994,0.1068
55,Tumor State 1,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0,0.0,0.1768,0.1971
56,Tumor State 1,HALLMARK_MYC_TARGETS_V2,0.0,0.0,0.0,0.0,0.2297,0.2472
57,Tumor State 1,HALLMARK_MYOGENESIS,0.0,0.0,0.0,0.0,0.1375,0.1508
58,Tumor State 1,HALLMARK_NOTCH_SIGNALING,0.0,0.0,0.0,0.0,0.4892,0.4734
59,Tumor State 1,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.3079,0.3006
60,Tumor State 1,HALLMARK_P53_PATHWAY,0.0,0.0,0.0,0.0,0.1375,0.143
61,Tumor State 1,HALLMARK_PANCREAS_BETA_CELLS,0.0,0.0,0.0,0.0,0.3649,0.3739
62,Tumor State 1,HALLMARK_PEROXISOME,0.0,0.0,0.0,0.0,0.2472,0.253
63,Tumor State 1,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.2297,0.2415
64,Tumor State 1,HALLMARK_PROTEIN_SECRETION,0.0,0.0,0.0,0.0,0.3352,0.3403
65,Tumor State 1,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.3649,0.3521
66,Tumor State 1,HALLMARK_SPERMATOGENESIS,0.003,0.0028,0.0,0.0,0.1375,0.1481
67,Tumor State 1,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0,0.0,0.0,0.3946,0.3868
68,Tumor State 1,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0,0.0,0.1375,0.1339
69,Tumor State 1,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0,0.0,0.0,0.0,0.2297,0.2399
70,Tumor State 1,HALLMARK_UV_RESPONSE_DN,0.0,0.0,0.0003,0.0002,0.4332,0.4177
71,Tumor State 1,HALLMARK_UV_RESPONSE_UP,0.0,0.0,0.0,0.0,0.2736,0.2937
72,Tumor State 1,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.0,0.0,0.0,0.0,0.1527,0.1751
73,Tumor State 1,HALLMARK_XENOBIOTIC_METABOLISM,0.0,0.0,0.0,0.0,0.2664,0.2604
74,Tumor State 1,ONCOGENIC_AKT_UP.V1_DN,0.0,0.0,0.0,0.0,0.0911,0.0994
75,Tumor State 1,ONCOGENIC_AKT_UP.V1_UP,0.0,0.0,0.0,0.0,0.1375,0.1526
76,Tumor State 1,ONCOGENIC_AKT_UP_MTOR_DN.V1_DN,0.0008,0.0012,0.0004,0.0007,0.1081,0.1205
77,Tumor State 1,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0,0.0,0.0,0.0,0.1451,0.158
78,Tumor State 1,ONCOGENIC_ALK_DN.V1_DN,0.0,0.0,0.0001,0.0001,0.1451,0.1621
79,Tumor State 1,ONCOGENIC_ALK_DN.V1_UP,0.0,0.0,0.0,0.0,0.1527,0.1752
80,Tumor State 1,ONCOGENIC_ATF2_S_UP.V1_DN,0.0,0.0,0.0,0.0,0.4218,0.4314
81,Tumor State 1,ONCOGENIC_ATF2_S_UP.V1_UP,0.0,0.0,0.0,0.0,0.0934,0.1056
82,Tumor State 1,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.3549,0.3655
83,Tumor State 1,ONCOGENIC_ATF2_UP.V1_UP,0.0,0.0,0.0,0.0,0.0934,0.0994
84,Tumor State 1,ONCOGENIC_ATM_DN.V1_DN,0.0,0.0,0.0,0.0,0.1831,0.1947
85,Tumor State 1,ONCOGENIC_ATM_DN.V1_UP,0.0,0.0,0.0,0.0,0.4103,0.4002
86,Tumor State 1,ONCOGENIC_BCAT.100_UP.V1_DN,0.0254,0.0248,0.003,0.0031,0.4442,0.4619
87,Tumor State 1,ONCOGENIC_BCAT.100_UP.V1_UP,0.015,0.0131,0.0014,0.0012,0.3234,0.3402
88,Tumor State 1,ONCOGENIC_BCAT_BILD_ET_AL_DN,0.1046,0.0922,0.0153,0.0129,0.2664,0.2697
89,Tumor State 1,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0091,0.0142,0.0702,0.0821,0.2297,0.2353
90,Tumor State 1,ONCOGENIC_BCAT_GDS748_DN,0.0,0.0,0.0,0.0,0.3946,0.4023
91,Tumor State 1,ONCOGENIC_BCAT_GDS748_UP,0.0403,0.0209,0.0036,0.0021,0.159,0.1945
92,Tumor State 1,ONCOGENIC_BMI1_DN.V1_DN,0.0,0.0,0.0,0.0,0.2909,0.3233
93,Tumor State 1,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.1381,0.1602
94,Tumor State 1,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0115,0.0125,0.0007,0.0009,0.2909,0.3022
95,Tumor State 1,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.2219,0.2305
97,Tumor State 1,ONCOGENIC_BRCA1_DN.V1_UP,0.0,0.0,0.0,0.0001,0.4695,0.454
98,Tumor State 1,ONCOGENIC_CAHOY_ASTROCYTIC,0.0,0.0,0.0,0.0,0.0911,0.0994
99,Tumor State 1,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.0999,0.1198
100,Tumor State 1,ONCOGENIC_CAHOY_NEURONAL,0.0,0.0,0.0,0.0,0.2909,0.3156
102,Tumor State 1,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.2664,0.2689
103,Tumor State 1,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.1984,0.2154
104,Tumor State 1,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0,0.0,0.0,0.0,0.1381,0.158
105,Tumor State 1,ONCOGENIC_CRX_DN.V1_DN,0.0,0.0,0.0,0.0,0.0491,0.0587
106,Tumor State 1,ONCOGENIC_CRX_DN.V1_UP,0.0,0.0,0.0021,0.0024,0.4442,0.4457
108,Tumor State 1,ONCOGENIC_CRX_NRL_DN.V1_UP,0.1479,0.1647,0.0004,0.0005,0.283,0.2916
109,Tumor State 1,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.1268,0.1293
110,Tumor State 1,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.1375,0.1561
111,Tumor State 1,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.2664,0.2791
112,Tumor State 1,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.1694,0.1917
113,Tumor State 1,ONCOGENIC_CTIP_DN.V1_DN,0.0,0.0,0.0,0.0,0.4332,0.4314
114,Tumor State 1,ONCOGENIC_CTIP_DN.V1_UP,0.0,0.0,0.001,0.0007,0.2736,0.2823
116,Tumor State 1,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0,0.0,0.0,0.0,0.159,0.1855
117,Tumor State 1,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.0999,0.1103
118,Tumor State 1,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0,0.0,0.0,0.0,0.1694,0.1855
119,Tumor State 1,ONCOGENIC_DCA_UP.V1_DN,0.0007,0.0011,0.0106,0.0138,0.1375,0.143
120,Tumor State 1,ONCOGENIC_DCA_UP.V1_UP,0.0,0.0,0.0,0.0,0.283,0.3006
122,Tumor State 1,ONCOGENIC_E2F1_UP.V1_UP,0.0,0.0,0.0,0.0,0.2736,0.2789
124,Tumor State 1,ONCOGENIC_E2F3_UP.V1_UP,0.0,0.0,0.0,0.0,0.4837,0.4716
125,Tumor State 1,ONCOGENIC_EGFR_UP.V1_DN,0.0,0.0,0.0,0.0,0.2297,0.2352
126,Tumor State 1,ONCOGENIC_EGFR_UP.V1_UP,0.0,0.0,0.0,0.0,0.0607,0.0676
127,Tumor State 1,ONCOGENIC_EIF4E_DN,0.0009,0.0016,0.0028,0.0048,0.283,0.3063
128,Tumor State 1,ONCOGENIC_EIF4E_UP,0.0,0.0,0.0,0.0,0.159,0.179
129,Tumor State 1,ONCOGENIC_ERBB2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4218,0.4271
130,Tumor State 1,ONCOGENIC_ERBB2_UP.V1_UP,0.0,0.0,0.0,0.0,0.0911,0.0982
131,Tumor State 1,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.3768,0.3809
133,Tumor State 1,ONCOGENIC_ESC_J1_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.209,0.2266
134,Tumor State 1,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.159,0.1817
135,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.1375,0.1559
136,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0006,0.0005,0.0015,0.0013,0.4218,0.4224
137,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.0999,0.1132
138,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.1375,0.143
139,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.1451,0.1684
140,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.209,0.232
141,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.1375,0.143
142,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.3234,0.3366
143,Tumor State 1,ONCOGENIC_GLI1_UP.V1_DN,0.0,0.0,0.0,0.0,0.1984,0.2099
144,Tumor State 1,ONCOGENIC_GLI1_UP.V1_UP,0.0,0.0,0.0017,0.0015,0.2297,0.2325
145,Tumor State 1,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.1375,0.143
146,Tumor State 1,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.3352,0.3578
147,Tumor State 1,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.083,0.0937
148,Tumor State 1,ONCOGENIC_HOXA9_DN.V1_UP,0.0108,0.0142,0.0429,0.0612,0.1375,0.1397
149,Tumor State 1,ONCOGENIC_IL15_UP.V1_DN,0.0133,0.0168,0.6988,0.6823,0.3352,0.3655
150,Tumor State 1,ONCOGENIC_IL15_UP.V1_UP,0.0,0.0,0.0,0.0,0.4103,0.4185
151,Tumor State 1,ONCOGENIC_IL21_UP.V1_DN,0.0,0.0,0.0,0.0,0.3768,0.3748
152,Tumor State 1,ONCOGENIC_IL21_UP.V1_UP,0.0,0.0,0.0,0.0,0.4442,0.4314
153,Tumor State 1,ONCOGENIC_IL2_UP.V1_DN,0.0,0.0,0.0,0.0,0.2736,0.2929
154,Tumor State 1,ONCOGENIC_IL2_UP.V1_UP,0.0,0.0,0.0,0.0,0.1768,0.1937
155,Tumor State 1,ONCOGENIC_JAK2_DN.V1_DN,0.0,0.0,0.0,0.0,0.0934,0.1035
156,Tumor State 1,ONCOGENIC_JAK2_DN.V1_UP,0.0002,0.0002,0.0017,0.0019,0.2736,0.2874
157,Tumor State 1,ONCOGENIC_JNK_DN.V1_DN,0.0,0.0,0.0,0.0,0.2664,0.2783
158,Tumor State 1,ONCOGENIC_JNK_DN.V1_UP,0.0066,0.0074,0.0,0.0,0.3649,0.3787
159,Tumor State 1,ONCOGENIC_KRAS.300_UP.V1_DN,0.0025,0.0016,0.0,0.0,0.3649,0.3809
160,Tumor State 1,ONCOGENIC_KRAS.300_UP.V1_UP,0.0,0.0,0.0,0.0,0.2297,0.2574
161,Tumor State 1,ONCOGENIC_KRAS.50_UP.V1_DN,0.0002,0.0004,0.0,0.0,0.1171,0.126
162,Tumor State 1,ONCOGENIC_KRAS.50_UP.V1_UP,0.0,0.0,0.0023,0.0012,0.1375,0.1553
163,Tumor State 1,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0,0.0,0.0,0.0,0.3649,0.3672
164,Tumor State 1,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0373,0.036,0.4953,0.387,0.3649,0.3747
165,Tumor State 1,ONCOGENIC_KRAS.600_UP.V1_DN,0.0078,0.0077,0.0001,0.0001,0.2736,0.2988
166,Tumor State 1,ONCOGENIC_KRAS.600_UP.V1_UP,0.0,0.0,0.0,0.0,0.4695,0.4676
167,Tumor State 1,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.283,0.2853
169,Tumor State 1,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0065,0.0051,0.0,0.0,0.4591,0.4393
170,Tumor State 1,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.2664,0.2783
171,Tumor State 1,ONCOGENIC_KRAS.DF.V1_DN,0.0009,0.0011,0.0002,0.0003,0.1831,0.2003
172,Tumor State 1,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.1375,0.1498
173,Tumor State 1,ONCOGENIC_KRAS.KIDNEY_UP.V1_DN,0.0,0.0,0.0,0.0,0.1527,0.1799
174,Tumor State 1,ONCOGENIC_KRAS.KIDNEY_UP.V1_UP,0.0106,0.007,0.0184,0.0111,0.159,0.1772
175,Tumor State 1,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0,0.0,0.0003,0.0004,0.2655,0.2613
176,Tumor State 1,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_UP,0.0,0.0,0.0002,0.0001,0.283,0.2935
177,Tumor State 1,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.1375,0.1529
178,Tumor State 1,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0,0.0,0.0011,0.0013,0.3768,0.3861
179,Tumor State 1,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.4695,0.4521
180,Tumor State 1,ONCOGENIC_KRAS.PROSTATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.3946,0.3936
181,Tumor State 1,ONCOGENIC_LEF1_UP.V1_DN,0.0,0.0,0.0,0.0,0.209,0.2309
182,Tumor State 1,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.0934,0.1064
183,Tumor State 1,ONCOGENIC_LTE2_UP.V1_DN,0.0,0.0,0.0005,0.0006,0.4591,0.4702
185,Tumor State 1,ONCOGENIC_MEK_UP.V1_DN,0.0,0.0,0.0,0.0,0.2664,0.2783
186,Tumor State 1,ONCOGENIC_MEK_UP.V1_UP,0.0,0.0,0.0,0.0,0.0719,0.0859
188,Tumor State 1,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.3352,0.3359
189,Tumor State 1,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0,0.0,0.0,0.0,0.4103,0.4075
190,Tumor State 1,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.0676,0.081
191,Tumor State 1,ONCOGENIC_MTOR_UP.V1_DN,0.0,0.0,0.0,0.0,0.134,0.1393
192,Tumor State 1,ONCOGENIC_MTOR_UP.V1_UP,0.0,0.0,0.0,0.0,0.1381,0.1637
194,Tumor State 1,ONCOGENIC_MYC_UP.V1_UP,0.0,0.0,0.0,0.0,0.1831,0.2003
195,Tumor State 1,ONCOGENIC_NFE2L2.V2,0.0243,0.0235,0.0,0.0001,0.1375,0.1553
196,Tumor State 1,ONCOGENIC_NOTCH_DN.V1_DN,0.0,0.0,0.0,0.0001,0.4218,0.4291
199,Tumor State 1,ONCOGENIC_NRL_DN.V1_UP,0.0003,0.0005,0.0,0.0,0.2664,0.2657
200,Tumor State 1,ONCOGENIC_P53_DN.V1_DN,0.0,0.0,0.0,0.0,0.1375,0.1469
202,Tumor State 1,ONCOGENIC_P53_DN.V2_DN,0.0,0.0,0.0,0.0,0.3234,0.3424
203,Tumor State 1,ONCOGENIC_P53_DN.V2_UP,0.0,0.0,0.0,0.0,0.1381,0.1561
205,Tumor State 1,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.2736,0.2685
207,Tumor State 1,ONCOGENIC_PDGF_UP.V1_UP,0.0397,0.0441,0.0262,0.0305,0.2664,0.273
208,Tumor State 1,ONCOGENIC_PIGF_UP.V1_DN,0.0002,0.0001,0.0001,0.0001,0.1831,0.2069
209,Tumor State 1,ONCOGENIC_PIGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.4695,0.4723
210,Tumor State 1,ONCOGENIC_PKCA_DN.V1_DN,0.0002,0.0002,0.0,0.0,0.1768,0.1953
211,Tumor State 1,ONCOGENIC_PKCA_DN.V1_UP,0.0,0.0,0.0,0.0,0.0999,0.1161
213,Tumor State 1,ONCOGENIC_PRC1_BMI_UP.V1_UP,0.0,0.0,0.0,0.0,0.1381,0.1651
214,Tumor State 1,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0129,0.0132,0.0025,0.0023,0.2655,0.2694
215,Tumor State 1,ONCOGENIC_PRC2_EED_UP.V1_UP,0.0,0.0,0.0,0.0,0.0934,0.1056
216,Tumor State 1,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.004,0.0051,0.0002,0.0003,0.2664,0.2801
217,Tumor State 1,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0001,0.0001,0.0001,0.0001,0.1375,0.1478
218,Tumor State 1,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0139,0.0138,0.0074,0.0083,0.4442,0.4481
219,Tumor State 1,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.009,0.0109,0.0136,0.0149,0.1831,0.2059
220,Tumor State 1,ONCOGENIC_PTEN_DN.V1_DN,0.0,0.0,0.0,0.0,0.134,0.1336
221,Tumor State 1,ONCOGENIC_PTEN_DN.V1_UP,0.0,0.0,0.0011,0.0011,0.3768,0.3739
222,Tumor State 1,ONCOGENIC_PTEN_DN.V2_DN,0.0,0.0,0.0,0.0,0.4695,0.4725
223,Tumor State 1,ONCOGENIC_PTEN_DN.V2_UP,0.024,0.0441,0.0007,0.0019,0.1694,0.1936
224,Tumor State 1,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.0617,0.0678
225,Tumor State 1,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0,0.0,0.0491,0.0587
226,Tumor State 1,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.0001,0.0001,0.0003,0.0004,0.1081,0.1161
229,Tumor State 1,ONCOGENIC_RB_DN.V1_UP,0.0,0.0,0.0,0.0,0.4591,0.4676
231,Tumor State 1,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.2909,0.2911
232,Tumor State 1,ONCOGENIC_RB_P130_DN.V1_DN,0.0134,0.0158,0.0575,0.0686,0.1831,0.2003
233,Tumor State 1,ONCOGENIC_RB_P130_DN.V1_UP,0.012,0.01,0.0219,0.0206,0.4837,0.4775
234,Tumor State 1,ONCOGENIC_RELA_DN.V1_DN,0.0,0.0,0.0,0.0,0.159,0.1786
235,Tumor State 1,ONCOGENIC_RELA_DN.V1_UP,0.1993,0.2231,0.0338,0.0485,0.3352,0.3557
236,Tumor State 1,ONCOGENIC_RPS14_DN.V1_DN,0.0,0.0,0.0,0.0,0.0999,0.1133
237,Tumor State 1,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.0999,0.1191
238,Tumor State 1,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0,0.0,0.0,0.0,0.4442,0.4599
239,Tumor State 1,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.0934,0.0994
240,Tumor State 1,ONCOGENIC_SIRNA_EIF4GI_UP,0.0,0.0,0.0,0.0,0.283,0.2853
241,Tumor State 1,ONCOGENIC_SNF5_DN.V1_DN,0.0,0.0,0.0,0.0,0.0934,0.0993
242,Tumor State 1,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.0617,0.0723
243,Tumor State 1,ONCOGENIC_SRC_UP.V1_DN,0.0,0.0,0.0,0.0,0.2909,0.31
245,Tumor State 1,ONCOGENIC_STK33_DN,0.0,0.0,0.0,0.0,0.1381,0.1559
246,Tumor State 1,ONCOGENIC_STK33_NOMO_DN,0.0,0.0,0.0,0.0,0.0994,0.1052
247,Tumor State 1,ONCOGENIC_STK33_NOMO_UP,0.0001,0.0001,0.0042,0.0056,0.3079,0.3128
248,Tumor State 1,ONCOGENIC_STK33_SKM_DN,0.0,0.0,0.0,0.0,0.1375,0.1391
249,Tumor State 1,ONCOGENIC_STK33_SKM_UP,0.0079,0.0086,0.2381,0.2238,0.4695,0.4599
250,Tumor State 1,ONCOGENIC_STK33_UP,0.0001,0.0,0.0,0.0,0.4892,0.4702
251,Tumor State 1,ONCOGENIC_TBK1.DF_DN,0.0002,0.0002,0.0001,0.0001,0.4591,0.4716
252,Tumor State 1,ONCOGENIC_TBK1.DF_UP,0.0,0.0,0.0,0.0,0.1375,0.146
253,Tumor State 1,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0,0.0,0.4332,0.4503
254,Tumor State 1,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0004,0.0008,0.1381,0.1619
255,Tumor State 1,ONCOGENIC_TGFB_UP.V1_DN,0.0,0.0,0.0,0.0,0.1381,0.1585
256,Tumor State 1,ONCOGENIC_TGFB_UP.V1_UP,0.0,0.0,0.0,0.0,0.4892,0.464
257,Tumor State 1,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.1375,0.1561
258,Tumor State 1,ONCOGENIC_VEGF_A_UP.V1_UP,0.0006,0.0006,0.0,0.0,0.3768,0.3822
259,Tumor State 1,ONCOGENIC_WNT_UP.V1_DN,0.0,0.0,0.0,0.0,0.1268,0.1268
261,Tumor State 1,ONCOGENIC_YAP1_DN,0.0,0.0,0.0,0.0,0.2219,0.2395
262,Tumor State 1,ONCOGENIC_YAP1_UP,0.0,0.0,0.0,0.0,0.0999,0.1182
1,Tumor State 2,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.5368,0.5652
2,Tumor State 2,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0001,0.0001,0.0002,0.0001,0.5368,0.5652
3,Tumor State 2,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.5368,0.5652
4,Tumor State 2,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0023,0.0019,0.0022,0.0018,0.5368,0.5652
5,Tumor State 2,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0018,0.0017,0.5368,0.5652
6,Tumor State 2,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.5368,0.5652
7,Tumor State 2,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0067,0.0064,0.0938,0.0842,0.5368,0.5652
9,Tumor State 2,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0152,0.0182,0.0226,0.0282,0.5368,0.5652
10,Tumor State 2,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0,0.0,0.0,0.5368,0.5652
11,Tumor State 2,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.5368,0.5652
13,Tumor State 2,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0,0.0,0.0,0.5368,0.5652
15,Tumor State 2,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0001,0.0001,0.5368,0.5652
16,Tumor State 2,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0,0.0011,0.0018,0.5368,0.5652
17,Tumor State 2,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0096,0.0114,0.5368,0.5652
18,Tumor State 2,ZHANG_INTERFERON_RESPONSE,0.0001,0.0001,0.5763,0.55,0.5368,0.5652
19,Tumor State 2,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0002,0.0002,0.0,0.0,0.5368,0.5652
20,Tumor State 2,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0,0.0,0.0,0.0,0.5368,0.5652
21,Tumor State 2,PAM50,0.0,0.0,0.0001,0.0001,0.5368,0.5652
22,Tumor State 2,WU_ET_AL_BASAL_SC,0.0,0.0,0.0,0.0,0.5368,0.5652
23,Tumor State 2,WU_ET_AL_HER2E_SC,0.0,0.0,0.0,0.0,0.5368,0.5652
24,Tumor State 2,WU_ET_AL_LUMA_SC,0.0,0.0,0.0,0.0,0.5368,0.5652
25,Tumor State 2,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.5368,0.5652
26,Tumor State 2,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.3243,0.3338
27,Tumor State 2,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.4703,0.4701
28,Tumor State 2,HALLMARK_ANDROGEN_RESPONSE,0.0,0.0,0.0,0.0,0.2363,0.2494
29,Tumor State 2,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0029,0.0041,0.3897,0.4151
30,Tumor State 2,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.2363,0.2494
31,Tumor State 2,HALLMARK_APICAL_SURFACE,0.0,0.0,0.0,0.0,0.2363,0.2494
32,Tumor State 2,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.4543,0.4684
33,Tumor State 2,HALLMARK_BILE_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.3694,0.3814
34,Tumor State 2,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0,0.0,0.0,0.0,0.3694,0.3743
35,Tumor State 2,HALLMARK_COAGULATION,0.0015,0.0015,0.0271,0.0259,0.4703,0.4684
36,Tumor State 2,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.3243,0.3392
37,Tumor State 2,HALLMARK_DNA_REPAIR,0.0053,0.0065,0.2107,0.2367,0.3243,0.3269
38,Tumor State 2,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.2363,0.2494
39,Tumor State 2,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.4305,0.4251
41,Tumor State 2,HALLMARK_ESTROGEN_RESPONSE_LATE,0.0423,0.0457,0.1021,0.1241,0.4749,0.4807
42,Tumor State 2,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.3005,0.3118
43,Tumor State 2,HALLMARK_G2M_CHECKPOINT,0.0352,0.0464,0.0665,0.0844,0.3243,0.3434
44,Tumor State 2,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.4703,0.4701
46,Tumor State 2,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.2363,0.2494
47,Tumor State 2,HALLMARK_HYPOXIA,0.0,0.0,0.0,0.0,0.4703,0.4684
48,Tumor State 2,HALLMARK_IL2_STAT5_SIGNALING,0.0,0.0,0.0,0.0,0.2363,0.2494
49,Tumor State 2,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.3474,0.3686
50,Tumor State 2,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.4305,0.4364
51,Tumor State 2,HALLMARK_KRAS_SIGNALING_DN,0.041,0.0456,0.0867,0.0933,0.4703,0.4684
52,Tumor State 2,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.2505,0.2635
53,Tumor State 2,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.3005,0.3092
54,Tumor State 2,HALLMARK_MTORC1_SIGNALING,0.0921,0.0457,0.0,0.0,0.3897,0.4032
55,Tumor State 2,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0003,0.0007,0.2848,0.294
56,Tumor State 2,HALLMARK_MYC_TARGETS_V2,0.0,0.0,0.0,0.0,0.2505,0.2677
57,Tumor State 2,HALLMARK_MYOGENESIS,0.0,0.0,0.0,0.0,0.3897,0.4251
58,Tumor State 2,HALLMARK_NOTCH_SIGNALING,0.0,0.0,0.0,0.0,0.2363,0.2544
59,Tumor State 2,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.4812,0.3612,0.0129,0.0085,0.4543,0.457
60,Tumor State 2,HALLMARK_P53_PATHWAY,0.0,0.0,0.0,0.0,0.3694,0.3987
61,Tumor State 2,HALLMARK_PANCREAS_BETA_CELLS,0.0003,0.0002,0.0,0.0,0.4749,0.4764
62,Tumor State 2,HALLMARK_PEROXISOME,0.0,0.0,0.0,0.0,0.3243,0.3208
63,Tumor State 2,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.3694,0.3814
64,Tumor State 2,HALLMARK_PROTEIN_SECRETION,0.0,0.0,0.0,0.0,0.3243,0.3482
65,Tumor State 2,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.316,0.1957,0.0148,0.0102,0.4703,0.4722
67,Tumor State 2,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0,0.0,0.0,0.2505,0.2635
68,Tumor State 2,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0,0.0,0.2848,0.3034
69,Tumor State 2,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0592,0.0456,0.0437,0.0326,0.3474,0.3714
70,Tumor State 2,HALLMARK_UV_RESPONSE_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
72,Tumor State 2,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.001,0.0011,0.0005,0.0005,0.3694,0.3964
73,Tumor State 2,HALLMARK_XENOBIOTIC_METABOLISM,0.0,0.0,0.0,0.0,0.2848,0.294
74,Tumor State 2,ONCOGENIC_AKT_UP.V1_DN,0.0,0.0,0.0,0.0,0.3005,0.3118
75,Tumor State 2,ONCOGENIC_AKT_UP.V1_UP,0.0,0.0,0.0,0.0,0.4749,0.4807
76,Tumor State 2,ONCOGENIC_AKT_UP_MTOR_DN.V1_DN,0.0027,0.0031,0.0071,0.0076,0.4305,0.4441
77,Tumor State 2,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0,0.0,0.0,0.0,0.3694,0.4032
78,Tumor State 2,ONCOGENIC_ALK_DN.V1_DN,0.0319,0.0499,0.0569,0.1082,0.2848,0.3034
79,Tumor State 2,ONCOGENIC_ALK_DN.V1_UP,0.0,0.0,0.0,0.0,0.4543,0.4661
80,Tumor State 2,ONCOGENIC_ATF2_S_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3482
81,Tumor State 2,ONCOGENIC_ATF2_S_UP.V1_UP,0.0,0.0,0.0,0.0,0.4703,0.4764
82,Tumor State 2,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.3005,0.3069
83,Tumor State 2,ONCOGENIC_ATF2_UP.V1_UP,0.0,0.0,0.0,0.0,0.3243,0.3208
85,Tumor State 2,ONCOGENIC_ATM_DN.V1_UP,0.0156,0.016,0.0063,0.0061,0.4703,0.4701
86,Tumor State 2,ONCOGENIC_BCAT.100_UP.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
87,Tumor State 2,ONCOGENIC_BCAT.100_UP.V1_UP,0.0,0.0,0.0,0.0,0.3005,0.3069
88,Tumor State 2,ONCOGENIC_BCAT_BILD_ET_AL_DN,0.0,0.0,0.0,0.0,0.2505,0.2596
89,Tumor State 2,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0,0.0,0.0,0.0,0.2363,0.2544
91,Tumor State 2,ONCOGENIC_BCAT_GDS748_UP,0.0,0.0,0.0,0.0,0.3243,0.3458
92,Tumor State 2,ONCOGENIC_BMI1_DN.V1_DN,0.0,0.0,0.0,0.0,0.4305,0.432
93,Tumor State 2,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.2795,0.2922
94,Tumor State 2,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.4749,0.4684
95,Tumor State 2,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.3694,0.3889
98,Tumor State 2,ONCOGENIC_CAHOY_ASTROCYTIC,0.0,0.0,0.0,0.0,0.4543,0.4661
99,Tumor State 2,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.3243,0.3411
100,Tumor State 2,ONCOGENIC_CAHOY_NEURONAL,0.1273,0.1208,0.0148,0.0148,0.4703,0.4701
101,Tumor State 2,ONCOGENIC_CAHOY_OLIGODENDROCUTIC,0.0001,0.0001,0.0,0.0,0.3474,0.372
102,Tumor State 2,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3338
104,Tumor State 2,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0,0.0,0.0001,0.0001,0.4749,0.4785
105,Tumor State 2,ONCOGENIC_CRX_DN.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
107,Tumor State 2,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
109,Tumor State 2,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3482
110,Tumor State 2,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.4749,0.4684
111,Tumor State 2,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3411
112,Tumor State 2,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0004,0.0008,0.0005,0.0008,0.3005,0.3104
113,Tumor State 2,ONCOGENIC_CTIP_DN.V1_DN,0.0,0.0,0.001,0.0011,0.3897,0.4251
114,Tumor State 2,ONCOGENIC_CTIP_DN.V1_UP,0.025,0.0325,0.0067,0.0091,0.2795,0.2767
115,Tumor State 2,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0,0.0,0.0,0.0,0.2848,0.3034
116,Tumor State 2,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0,0.0,0.0,0.0,0.3474,0.3743
117,Tumor State 2,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.2505,0.2635
120,Tumor State 2,ONCOGENIC_DCA_UP.V1_UP,0.0001,0.0001,0.0003,0.0003,0.2795,0.2922
121,Tumor State 2,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0,0.0,0.3474,0.3633
122,Tumor State 2,ONCOGENIC_E2F1_UP.V1_UP,0.0,0.0,0.0,0.0,0.4749,0.5
123,Tumor State 2,ONCOGENIC_E2F3_UP.V1_DN,0.0023,0.0026,0.0042,0.0049,0.3005,0.3118
125,Tumor State 2,ONCOGENIC_EGFR_UP.V1_DN,0.0,0.0,0.0,0.0,0.4543,0.4387
126,Tumor State 2,ONCOGENIC_EGFR_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
127,Tumor State 2,ONCOGENIC_EIF4E_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
128,Tumor State 2,ONCOGENIC_EIF4E_UP,0.0128,0.0184,0.1346,0.1498,0.3243,0.3208
129,Tumor State 2,ONCOGENIC_ERBB2_UP.V1_DN,0.0002,0.0001,0.0002,0.0001,0.4543,0.4638
130,Tumor State 2,ONCOGENIC_ERBB2_UP.V1_UP,0.0,0.0,0.0,0.0,0.2848,0.2822
131,Tumor State 2,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.4703,0.4684
134,Tumor State 2,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.2505,0.2635
135,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
136,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
137,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0006,0.0006,0.0034,0.0037,0.4543,0.4684
138,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
139,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.3897,0.4143
140,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0001,0.0001,0.0001,0.0001,0.3897,0.4032
141,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3506
142,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.3005,0.3092
143,Tumor State 2,ONCOGENIC_GLI1_UP.V1_DN,0.0,0.0,0.0,0.0,0.2848,0.3
144,Tumor State 2,ONCOGENIC_GLI1_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
145,Tumor State 2,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.3243,0.3506
146,Tumor State 2,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.3694,0.3964
147,Tumor State 2,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.4543,0.432
148,Tumor State 2,ONCOGENIC_HOXA9_DN.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
150,Tumor State 2,ONCOGENIC_IL15_UP.V1_UP,0.0,0.0,0.0,0.0,0.3005,0.3112
152,Tumor State 2,ONCOGENIC_IL21_UP.V1_UP,0.0,0.0,0.0003,0.0003,0.3694,0.3814
154,Tumor State 2,ONCOGENIC_IL2_UP.V1_UP,0.0033,0.0043,0.0015,0.0019,0.3474,0.3697
157,Tumor State 2,ONCOGENIC_JNK_DN.V1_DN,0.0303,0.0322,0.1182,0.1316,0.3243,0.3482
158,Tumor State 2,ONCOGENIC_JNK_DN.V1_UP,0.0269,0.0273,0.01,0.0109,0.3474,0.3697
159,Tumor State 2,ONCOGENIC_KRAS.300_UP.V1_DN,0.0,0.0,0.0,0.0,0.2795,0.2767
160,Tumor State 2,ONCOGENIC_KRAS.300_UP.V1_UP,0.0,0.0,0.0015,0.0021,0.2505,0.2635
161,Tumor State 2,ONCOGENIC_KRAS.50_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3269
163,Tumor State 2,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0005,0.0005,0.0002,0.0001,0.3897,0.4251
164,Tumor State 2,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0046,0.0058,0.0078,0.0108,0.3474,0.3458
166,Tumor State 2,ONCOGENIC_KRAS.600_UP.V1_UP,0.0,0.0,0.0,0.0,0.2848,0.2883
167,Tumor State 2,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0003,0.0003,0.0021,0.002,0.4703,0.4684
168,Tumor State 2,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.0164,0.0172,0.0101,0.0106,0.4543,0.4684
169,Tumor State 2,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0478,0.0517,0.0069,0.0072,0.3243,0.3434
170,Tumor State 2,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.0055,0.0068,0.002,0.0027,0.3243,0.3269
171,Tumor State 2,ONCOGENIC_KRAS.DF.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3208
172,Tumor State 2,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.3694,0.3839
173,Tumor State 2,ONCOGENIC_KRAS.KIDNEY_UP.V1_DN,0.0027,0.004,0.0023,0.004,0.2848,0.294
174,Tumor State 2,ONCOGENIC_KRAS.KIDNEY_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
175,Tumor State 2,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.033,0.0381,0.1455,0.1629,0.3474,0.3652
176,Tumor State 2,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_UP,0.0014,0.0015,0.0004,0.0004,0.3474,0.3458
177,Tumor State 2,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.4749,0.5
179,Tumor State 2,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
180,Tumor State 2,ONCOGENIC_KRAS.PROSTATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.2848,0.3
181,Tumor State 2,ONCOGENIC_LEF1_UP.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
182,Tumor State 2,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.4749,0.4851
183,Tumor State 2,ONCOGENIC_LTE2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4749,0.4807
184,Tumor State 2,ONCOGENIC_LTE2_UP.V1_UP,0.0,0.0,0.0,0.0,0.2795,0.2767
185,Tumor State 2,ONCOGENIC_MEK_UP.V1_DN,0.0,0.0,0.0,0.0,0.4749,0.4918
186,Tumor State 2,ONCOGENIC_MEK_UP.V1_UP,0.0,0.0,0.0,0.0,0.2848,0.2842
187,Tumor State 2,ONCOGENIC_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.4749,0.4684
188,Tumor State 2,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.3694,0.3964
189,Tumor State 2,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
190,Tumor State 2,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.4703,0.4743
191,Tumor State 2,ONCOGENIC_MTOR_UP.V1_DN,0.0,0.0,0.0,0.0,0.3694,0.4032
192,Tumor State 2,ONCOGENIC_MTOR_UP.V1_UP,0.0,0.0,0.0,0.0,0.2848,0.2922
193,Tumor State 2,ONCOGENIC_MYC_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3334
194,Tumor State 2,ONCOGENIC_MYC_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
195,Tumor State 2,ONCOGENIC_NFE2L2.V2,0.0,0.0,0.0,0.0,0.3897,0.4079
196,Tumor State 2,ONCOGENIC_NOTCH_DN.V1_DN,0.0,0.0,0.0,0.0,0.3474,0.3674
197,Tumor State 2,ONCOGENIC_NOTCH_DN.V1_UP,0.008,0.0099,0.0051,0.0062,0.2848,0.3
198,Tumor State 2,ONCOGENIC_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.3005,0.3118
199,Tumor State 2,ONCOGENIC_NRL_DN.V1_UP,0.0023,0.0023,0.0026,0.0025,0.3897,0.4251
200,Tumor State 2,ONCOGENIC_P53_DN.V1_DN,0.0,0.0,0.0,0.0,0.3897,0.4032
201,Tumor State 2,ONCOGENIC_P53_DN.V1_UP,0.0,0.0,0.0,0.0,0.3243,0.3458
202,Tumor State 2,ONCOGENIC_P53_DN.V2_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
203,Tumor State 2,ONCOGENIC_P53_DN.V2_UP,0.0,0.0,0.0,0.0,0.3243,0.3338
204,Tumor State 2,ONCOGENIC_PDGF_ERK_DN.V1_DN,0.0,0.0,0.0001,0.0002,0.3243,0.3556
205,Tumor State 2,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
206,Tumor State 2,ONCOGENIC_PDGF_UP.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
207,Tumor State 2,ONCOGENIC_PDGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.3243,0.3491
208,Tumor State 2,ONCOGENIC_PIGF_UP.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
209,Tumor State 2,ONCOGENIC_PIGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
210,Tumor State 2,ONCOGENIC_PKCA_DN.V1_DN,0.0,0.0,0.0,0.0,0.3005,0.3118
211,Tumor State 2,ONCOGENIC_PKCA_DN.V1_UP,0.0,0.0,0.0,0.0,0.4703,0.4684
212,Tumor State 2,ONCOGENIC_PRC1_BMI_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3342
213,Tumor State 2,ONCOGENIC_PRC1_BMI_UP.V1_UP,0.0179,0.0178,0.0009,0.0009,0.4543,0.4638
214,Tumor State 2,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0,0.0,0.0,0.0,0.3243,0.3342
215,Tumor State 2,ONCOGENIC_PRC2_EED_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
216,Tumor State 2,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0397,0.0363,0.0175,0.0162,0.3897,0.4032
217,Tumor State 2,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0,0.0,0.0,0.0,0.2848,0.3034
218,Tumor State 2,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0604,0.0688,0.018,0.0217,0.3005,0.314
219,Tumor State 2,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.0,0.0,0.0,0.0,0.3897,0.4229
221,Tumor State 2,ONCOGENIC_PTEN_DN.V1_UP,0.0081,0.0082,0.0034,0.0034,0.3897,0.4251
222,Tumor State 2,ONCOGENIC_PTEN_DN.V2_DN,0.0011,0.001,0.0008,0.0007,0.4703,0.4684
223,Tumor State 2,ONCOGENIC_PTEN_DN.V2_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
224,Tumor State 2,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.4703,0.4661
225,Tumor State 2,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
227,Tumor State 2,ONCOGENIC_RAPA_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.2505,0.2674
228,Tumor State 2,ONCOGENIC_RB_DN.V1_DN,0.0561,0.072,0.0326,0.0427,0.2363,0.2525
230,Tumor State 2,ONCOGENIC_RB_P107_DN.V1_DN,0.0,0.0,0.0,0.0,0.2795,0.2883
232,Tumor State 2,ONCOGENIC_RB_P130_DN.V1_DN,0.0,0.0,0.0,0.0,0.3005,0.3269
233,Tumor State 2,ONCOGENIC_RB_P130_DN.V1_UP,0.0022,0.0043,0.0165,0.0283,0.2363,0.2494
235,Tumor State 2,ONCOGENIC_RELA_DN.V1_UP,0.0011,0.0014,0.0841,0.1011,0.3243,0.3208
237,Tumor State 2,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.2795,0.2844
238,Tumor State 2,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0,0.0,0.0,0.0,0.2505,0.2635
239,Tumor State 2,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
240,Tumor State 2,ONCOGENIC_SIRNA_EIF4GI_UP,0.0,0.0,0.0,0.0,0.3243,0.3392
241,Tumor State 2,ONCOGENIC_SNF5_DN.V1_DN,0.0,0.0,0.0,0.0,0.3005,0.3118
242,Tumor State 2,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.4703,0.4684
243,Tumor State 2,ONCOGENIC_SRC_UP.V1_DN,0.0485,0.0555,0.2294,0.2493,0.3243,0.3342
244,Tumor State 2,ONCOGENIC_SRC_UP.V1_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
245,Tumor State 2,ONCOGENIC_STK33_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
246,Tumor State 2,ONCOGENIC_STK33_NOMO_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
247,Tumor State 2,ONCOGENIC_STK33_NOMO_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
248,Tumor State 2,ONCOGENIC_STK33_SKM_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
249,Tumor State 2,ONCOGENIC_STK33_SKM_UP,0.0,0.0,0.0,0.0,0.3243,0.3506
250,Tumor State 2,ONCOGENIC_STK33_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
251,Tumor State 2,ONCOGENIC_TBK1.DF_DN,0.0,0.0,0.0,0.0,0.2363,0.2525
252,Tumor State 2,ONCOGENIC_TBK1.DF_UP,0.0,0.0,0.0,0.0,0.2363,0.2494
253,Tumor State 2,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0,0.0,0.3694,0.3814
254,Tumor State 2,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0,0.0,0.4543,0.4548
255,Tumor State 2,ONCOGENIC_TGFB_UP.V1_DN,0.0,0.0,0.0,0.0,0.3694,0.3987
256,Tumor State 2,ONCOGENIC_TGFB_UP.V1_UP,0.0,0.0,0.0,0.0,0.3694,0.4009
257,Tumor State 2,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.2363,0.2494
258,Tumor State 2,ONCOGENIC_VEGF_A_UP.V1_UP,0.0002,0.0002,0.0003,0.0004,0.2848,0.2922
259,Tumor State 2,ONCOGENIC_WNT_UP.V1_DN,0.0,0.0,0.0,0.0,0.4749,0.4764
261,Tumor State 2,ONCOGENIC_YAP1_DN,0.0106,0.0088,0.0061,0.005,0.4543,0.4668
262,Tumor State 2,ONCOGENIC_YAP1_UP,0.0,0.0,0.0,0.0,0.2505,0.2635
1,Tumor State 3,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.3212,0.2642,0.0336,0.0442,0.4943,0.4791
2,Tumor State 3,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0004,0.0001,0.4943,0.4791
3,Tumor State 3,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.4943,0.4791
4,Tumor State 3,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0075,0.0042,0.2856,0.0993,0.4943,0.4791
5,Tumor State 3,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0,0.0,0.5322,0.527
6,Tumor State 3,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.5322,0.5147
7,Tumor State 3,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.5594,0.3684,0.0,0.0,0.4943,0.4791
10,Tumor State 3,REACTOME_INTERFERON_GAMMA_SIGNALING,0.1291,0.0339,0.2993,0.1334,0.4943,0.4946
11,Tumor State 3,REACTOME_INTERFERON_SIGNALING,0.1452,0.0578,0.0178,0.0021,0.4943,0.4791
15,Tumor State 3,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.001,0.0039,0.4943,0.4791
16,Tumor State 3,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.4373,0.4791
17,Tumor State 3,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0,0.0,0.516,0.527
18,Tumor State 3,ZHANG_INTERFERON_RESPONSE,0.2066,0.0959,0.0,0.0,0.4943,0.51
19,Tumor State 3,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0072,0.0086,0.049,0.0609,0.4373,0.4791
21,Tumor State 3,PAM50,0.0,0.0,0.0005,0.0002,0.516,0.5147
23,Tumor State 3,WU_ET_AL_HER2E_SC,0.0769,0.0931,0.0174,0.0284,0.4943,0.4791
24,Tumor State 3,WU_ET_AL_LUMA_SC,0.0,0.0,0.0,0.0,0.5322,0.5652
25,Tumor State 3,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.4943,0.527
26,Tumor State 3,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.1475,0.1895
27,Tumor State 3,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.4708,0.4662
28,Tumor State 3,HALLMARK_ANDROGEN_RESPONSE,0.0,0.0,0.0,0.0,0.4691,0.4662
29,Tumor State 3,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0,0.0,0.1827,0.2371
30,Tumor State 3,HALLMARK_APICAL_JUNCTION,0.0003,0.0003,0.0,0.0,0.4544,0.4619
31,Tumor State 3,HALLMARK_APICAL_SURFACE,0.028,0.0277,0.0048,0.0048,0.4708,0.4662
32,Tumor State 3,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.4544,0.4619
34,Tumor State 3,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0447,0.0556,0.0049,0.0067,0.3783,0.3882
35,Tumor State 3,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0,0.4544,0.4619
36,Tumor State 3,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.4691,0.4662
37,Tumor State 3,HALLMARK_DNA_REPAIR,0.0,0.0,0.0,0.0,0.1475,0.1895
38,Tumor State 3,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.1011,0.1399
39,Tumor State 3,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.028,0.0198,0.0,0.0,0.4708,0.4662
40,Tumor State 3,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0,0.0,0.0,0.0,0.4691,0.4662
41,Tumor State 3,HALLMARK_ESTROGEN_RESPONSE_LATE,0.0,0.0,0.0,0.0,0.4544,0.4619
42,Tumor State 3,HALLMARK_FATTY_ACID_METABOLISM,0.0337,0.0641,0.002,0.0066,0.1827,0.2106
43,Tumor State 3,HALLMARK_G2M_CHECKPOINT,0.0,0.0,0.0,0.0,0.1011,0.1399
44,Tumor State 3,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.2042,0.2399
45,Tumor State 3,HALLMARK_HEDGEHOG_SIGNALING,0.0513,0.0315,0.3401,0.2311,0.4708,0.5
46,Tumor State 3,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.2606,0.2956
47,Tumor State 3,HALLMARK_HYPOXIA,0.0,0.0,0.0,0.0,0.3783,0.3903
48,Tumor State 3,HALLMARK_IL2_STAT5_SIGNALING,0.0016,0.0019,0.0099,0.0124,0.4708,0.4753
50,Tumor State 3,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.4489,0.4562
51,Tumor State 3,HALLMARK_KRAS_SIGNALING_DN,0.0,0.0,0.0,0.0,0.1475,0.1895
52,Tumor State 3,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.4339,0.4431
53,Tumor State 3,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.4489,0.459
54,Tumor State 3,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.1475,0.1936
55,Tumor State 3,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0,0.0,0.1252,0.1526
56,Tumor State 3,HALLMARK_MYC_TARGETS_V2,0.0,0.0,0.0,0.0,0.1131,0.1479
57,Tumor State 3,HALLMARK_MYOGENESIS,0.0009,0.0012,0.016,0.02,0.4708,0.4774
59,Tumor State 3,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0076,0.0214,0.0,0.0001,0.1827,0.2055
60,Tumor State 3,HALLMARK_P53_PATHWAY,0.0,0.0,0.0,0.0,0.4708,0.4753
61,Tumor State 3,HALLMARK_PANCREAS_BETA_CELLS,0.0,0.0001,0.0007,0.0021,0.1475,0.1818
62,Tumor State 3,HALLMARK_PEROXISOME,0.0,0.0,0.0,0.0,0.2042,0.2541
63,Tumor State 3,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.3068,0.3147
64,Tumor State 3,HALLMARK_PROTEIN_SECRETION,0.0015,0.0014,0.0019,0.0017,0.4489,0.4569
65,Tumor State 3,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.2042,0.2541
66,Tumor State 3,HALLMARK_SPERMATOGENESIS,0.0,0.0,0.0,0.0,0.1475,0.1661
67,Tumor State 3,HALLMARK_TGF_BETA_SIGNALING,0.4001,0.302,0.0423,0.0305,0.4708,0.5
68,Tumor State 3,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0007,0.0011,0.3493,0.3796
69,Tumor State 3,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0,0.0,0.0,0.0,0.1252,0.1526
71,Tumor State 3,HALLMARK_UV_RESPONSE_UP,0.0,0.0,0.0,0.0,0.2042,0.255
72,Tumor State 3,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.0005,0.0008,0.0184,0.0256,0.4544,0.4562
73,Tumor State 3,HALLMARK_XENOBIOTIC_METABOLISM,0.0002,0.0001,0.0006,0.0003,0.4708,0.4774
75,Tumor State 3,ONCOGENIC_AKT_UP.V1_UP,0.0,0.0,0.0,0.0,0.4708,0.4753
76,Tumor State 3,ONCOGENIC_AKT_UP_MTOR_DN.V1_DN,0.0003,0.0002,0.0,0.0,0.4708,0.5
77,Tumor State 3,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0,0.0,0.0,0.0,0.4708,0.4774
78,Tumor State 3,ONCOGENIC_ALK_DN.V1_DN,0.0,0.0,0.0,0.0,0.3068,0.3218
79,Tumor State 3,ONCOGENIC_ALK_DN.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4634
81,Tumor State 3,ONCOGENIC_ATF2_S_UP.V1_UP,0.0016,0.0013,0.0046,0.0037,0.4708,0.4753
82,Tumor State 3,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4662
83,Tumor State 3,ONCOGENIC_ATF2_UP.V1_UP,0.0001,0.0001,0.0002,0.0001,0.4708,0.5
84,Tumor State 3,ONCOGENIC_ATM_DN.V1_DN,0.0,0.0,0.0,0.0,0.3068,0.3218
85,Tumor State 3,ONCOGENIC_ATM_DN.V1_UP,0.0,0.0,0.0,0.0,0.1252,0.1526
87,Tumor State 3,ONCOGENIC_BCAT.100_UP.V1_UP,0.0084,0.0075,0.0007,0.0005,0.4708,0.5
88,Tumor State 3,ONCOGENIC_BCAT_BILD_ET_AL_DN,0.0001,0.0,0.0004,0.0004,0.4544,0.4612
89,Tumor State 3,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.1004,0.0567,0.0096,0.0025,0.4544,0.4639
90,Tumor State 3,ONCOGENIC_BCAT_GDS748_DN,0.0,0.0,0.0,0.0,0.4339,0.4332
91,Tumor State 3,ONCOGENIC_BCAT_GDS748_UP,0.1164,0.0646,0.0182,0.0133,0.4691,0.4662
92,Tumor State 3,ONCOGENIC_BMI1_DN.V1_DN,0.0614,0.0258,0.0058,0.0038,0.4691,0.4662
93,Tumor State 3,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.4691,0.4662
94,Tumor State 3,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.1996,0.1105,0.0165,0.0041,0.4544,0.4619
95,Tumor State 3,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4619
96,Tumor State 3,ONCOGENIC_BRCA1_DN.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4569
97,Tumor State 3,ONCOGENIC_BRCA1_DN.V1_UP,0.0,0.0,0.0,0.0,0.3493,0.3564
98,Tumor State 3,ONCOGENIC_CAHOY_ASTROCYTIC,0.0,0.0,0.0,0.0,0.3068,0.2964
99,Tumor State 3,ONCOGENIC_CAHOY_ASTROGLIAL,0.0001,0.0001,0.0,0.0,0.4691,0.4662
101,Tumor State 3,ONCOGENIC_CAHOY_OLIGODENDROCUTIC,0.002,0.0025,0.0004,0.0006,0.4708,0.4753
102,Tumor State 3,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4619
103,Tumor State 3,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.1827,0.2541
105,Tumor State 3,ONCOGENIC_CRX_DN.V1_DN,0.0022,0.0028,0.006,0.0072,0.4708,0.5
107,Tumor State 3,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4619
108,Tumor State 3,ONCOGENIC_CRX_NRL_DN.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.459
109,Tumor State 3,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0453,0.054,0.1152,0.1181,0.4708,0.4774
110,Tumor State 3,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4619
111,Tumor State 3,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0843,0.0329,0.2173,0.0536,0.4489,0.4569
112,Tumor State 3,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0001,0.0002,0.0,0.0,0.3783,0.3771
113,Tumor State 3,ONCOGENIC_CTIP_DN.V1_DN,0.0002,0.0004,0.0009,0.0014,0.2606,0.2865
114,Tumor State 3,ONCOGENIC_CTIP_DN.V1_UP,0.0,0.0,0.0,0.0,0.2042,0.255
115,Tumor State 3,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0003,0.0005,0.0007,0.0009,0.4544,0.4639
117,Tumor State 3,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.3493,0.368
118,Tumor State 3,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0855,0.0836,0.0476,0.0484,0.4708,0.4753
119,Tumor State 3,ONCOGENIC_DCA_UP.V1_DN,0.002,0.0017,0.0021,0.0016,0.4691,0.459
120,Tumor State 3,ONCOGENIC_DCA_UP.V1_UP,0.0065,0.0084,0.0014,0.0016,0.4489,0.4569
121,Tumor State 3,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0009,0.0007,0.4708,0.4774
122,Tumor State 3,ONCOGENIC_E2F1_UP.V1_UP,0.0,0.0,0.0,0.0,0.1131,0.1479
124,Tumor State 3,ONCOGENIC_E2F3_UP.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.1657
125,Tumor State 3,ONCOGENIC_EGFR_UP.V1_DN,0.0034,0.0014,0.0649,0.0293,0.4708,0.4774
126,Tumor State 3,ONCOGENIC_EGFR_UP.V1_UP,0.0017,0.0017,0.0021,0.0022,0.4708,0.4753
127,Tumor State 3,ONCOGENIC_EIF4E_DN,0.0,0.0,0.0,0.0,0.4544,0.4662
128,Tumor State 3,ONCOGENIC_EIF4E_UP,0.0,0.0,0.0,0.0,0.1475,0.1681
131,Tumor State 3,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4662
134,Tumor State 3,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4619
135,Tumor State 3,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.4489,0.4569
136,Tumor State 3,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.3068,0.3147
137,Tumor State 3,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.459
138,Tumor State 3,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.1818
139,Tumor State 3,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0425,0.0433,0.0403,0.0476,0.4691,0.4662
140,Tumor State 3,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.1011,0.1399
141,Tumor State 3,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.4708,0.5
142,Tumor State 3,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.1895
145,Tumor State 3,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.4544,0.4662
146,Tumor State 3,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.4708,0.4753
147,Tumor State 3,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.1011,0.1399
148,Tumor State 3,ONCOGENIC_HOXA9_DN.V1_UP,0.0,0.0,0.0,0.0,0.4708,0.4753
149,Tumor State 3,ONCOGENIC_IL15_UP.V1_DN,0.0,0.0,0.0,0.0,0.3493,0.3637
150,Tumor State 3,ONCOGENIC_IL15_UP.V1_UP,0.001,0.0006,0.0134,0.0059,0.4708,0.4753
151,Tumor State 3,ONCOGENIC_IL21_UP.V1_DN,0.0037,0.004,0.001,0.0011,0.4339,0.4019
153,Tumor State 3,ONCOGENIC_IL2_UP.V1_DN,0.0,0.0,0.0,0.0,0.3493,0.362
154,Tumor State 3,ONCOGENIC_IL2_UP.V1_UP,0.019,0.0098,0.0148,0.0063,0.4708,0.4753
155,Tumor State 3,ONCOGENIC_JAK2_DN.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4562
156,Tumor State 3,ONCOGENIC_JAK2_DN.V1_UP,0.0,0.0,0.0,0.0,0.4489,0.4562
158,Tumor State 3,ONCOGENIC_JNK_DN.V1_UP,0.0002,0.0001,0.0001,0.0001,0.4544,0.4591
159,Tumor State 3,ONCOGENIC_KRAS.300_UP.V1_DN,0.0,0.0,0.0,0.0,0.1827,0.2197
160,Tumor State 3,ONCOGENIC_KRAS.300_UP.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4535
161,Tumor State 3,ONCOGENIC_KRAS.50_UP.V1_DN,0.0,0.0,0.0,0.0,0.1475,0.1614
162,Tumor State 3,ONCOGENIC_KRAS.50_UP.V1_UP,0.0271,0.0306,0.9846,0.7065,0.4544,0.4662
163,Tumor State 3,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4619
164,Tumor State 3,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.1661
165,Tumor State 3,ONCOGENIC_KRAS.600_UP.V1_DN,0.0,0.0,0.0,0.0,0.1475,0.2011
166,Tumor State 3,ONCOGENIC_KRAS.600_UP.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.2055
167,Tumor State 3,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.1475,0.2055
168,Tumor State 3,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.0005,0.0005,0.0,0.0001,0.3783,0.3905
169,Tumor State 3,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0314,0.0322,0.0898,0.0931,0.4691,0.4662
170,Tumor State 3,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.1011,0.1399
171,Tumor State 3,ONCOGENIC_KRAS.DF.V1_DN,0.0011,0.0018,0.0012,0.0022,0.4691,0.4663
172,Tumor State 3,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.4691,0.4662
173,Tumor State 3,ONCOGENIC_KRAS.KIDNEY_UP.V1_DN,0.0,0.0,0.0,0.0,0.1475,0.2017
174,Tumor State 3,ONCOGENIC_KRAS.KIDNEY_UP.V1_UP,0.0,0.0,0.0,0.0,0.4708,0.4662
175,Tumor State 3,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0,0.0,0.0,0.0,0.1475,0.2011
176,Tumor State 3,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.1011,0.1399
177,Tumor State 3,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.2042,0.2546
178,Tumor State 3,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0,0.0,0.0,0.0,0.3493,0.3771
179,Tumor State 3,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.4339,0.4048
180,Tumor State 3,ONCOGENIC_KRAS.PROSTATE_UP.V1_UP,0.0047,0.0057,0.0006,0.0008,0.4544,0.4569
181,Tumor State 3,ONCOGENIC_LEF1_UP.V1_DN,0.0,0.0,0.0,0.0,0.4708,0.4662
182,Tumor State 3,ONCOGENIC_LEF1_UP.V1_UP,0.0178,0.0173,0.7443,0.324,0.4708,0.4663
183,Tumor State 3,ONCOGENIC_LTE2_UP.V1_DN,0.0005,0.0002,0.0,0.0,0.3783,0.4124
184,Tumor State 3,ONCOGENIC_LTE2_UP.V1_UP,0.0064,0.0102,0.0,0.0,0.4544,0.4591
185,Tumor State 3,ONCOGENIC_MEK_UP.V1_DN,0.0135,0.0075,0.0001,0.0,0.4489,0.459
186,Tumor State 3,ONCOGENIC_MEK_UP.V1_UP,0.0012,0.0009,0.0006,0.0004,0.4544,0.4619
187,Tumor State 3,ONCOGENIC_MEL18_DN.V1_DN,0.0031,0.0016,0.0,0.0,0.4544,0.4639
188,Tumor State 3,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4619
189,Tumor State 3,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0084,0.0118,0.0074,0.0108,0.4339,0.4243
190,Tumor State 3,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.2042,0.2546
191,Tumor State 3,ONCOGENIC_MTOR_UP.V1_DN,0.0,0.0,0.0,0.0,0.4339,0.4289
192,Tumor State 3,ONCOGENIC_MTOR_UP.V1_UP,0.0008,0.0004,0.0034,0.0027,0.4691,0.4662
193,Tumor State 3,ONCOGENIC_MYC_UP.V1_DN,0.0,0.0,0.0,0.0,0.4339,0.4431
194,Tumor State 3,ONCOGENIC_MYC_UP.V1_UP,0.0,0.0,0.0,0.0,0.1011,0.1399
195,Tumor State 3,ONCOGENIC_NFE2L2.V2,0.1227,0.0491,0.6777,0.2203,0.4489,0.4569
196,Tumor State 3,ONCOGENIC_NOTCH_DN.V1_DN,0.0,0.0,0.0,0.0,0.3783,0.4022
198,Tumor State 3,ONCOGENIC_NRL_DN.V1_DN,0.022,0.03,0.0247,0.0354,0.4544,0.4619
199,Tumor State 3,ONCOGENIC_NRL_DN.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4662
200,Tumor State 3,ONCOGENIC_P53_DN.V1_DN,0.0021,0.0031,0.0214,0.0327,0.4691,0.4663
201,Tumor State 3,ONCOGENIC_P53_DN.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4662
202,Tumor State 3,ONCOGENIC_P53_DN.V2_DN,0.0,0.0,0.0,0.0,0.1475,0.1936
204,Tumor State 3,ONCOGENIC_PDGF_ERK_DN.V1_DN,0.0,0.0,0.0,0.0,0.2042,0.2541
205,Tumor State 3,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4619
206,Tumor State 3,ONCOGENIC_PDGF_UP.V1_DN,0.0499,0.0719,0.0183,0.0254,0.4489,0.4535
208,Tumor State 3,ONCOGENIC_PIGF_UP.V1_DN,0.0,0.0,0.0016,0.002,0.4489,0.4535
210,Tumor State 3,ONCOGENIC_PKCA_DN.V1_DN,0.0,0.0,0.0,0.0,0.4708,0.4753
211,Tumor State 3,ONCOGENIC_PKCA_DN.V1_UP,0.0,0.0,0.0,0.0,0.3783,0.4048
213,Tumor State 3,ONCOGENIC_PRC1_BMI_UP.V1_UP,0.0452,0.0594,0.0558,0.0735,0.3493,0.3771
214,Tumor State 3,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0,0.0,0.0,0.0,0.4489,0.4569
216,Tumor State 3,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0,0.0,0.0,0.0,0.1475,0.1978
217,Tumor State 3,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0,0.0,0.0,0.0,0.4544,0.4619
218,Tumor State 3,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0245,0.0207,0.0185,0.015,0.4708,0.4662
219,Tumor State 3,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.0,0.0,0.0,0.0,0.4489,0.4619
222,Tumor State 3,ONCOGENIC_PTEN_DN.V2_DN,0.0,0.0,0.0,0.0,0.4489,0.4332
223,Tumor State 3,ONCOGENIC_PTEN_DN.V2_UP,0.0,0.0,0.0,0.0,0.2042,0.2546
224,Tumor State 3,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.4708,0.4753
225,Tumor State 3,ONCOGENIC_RAF_UP.V1_UP,0.0248,0.0128,0.1043,0.0347,0.4544,0.4662
226,Tumor State 3,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.1296,0.1552,0.0149,0.0222,0.4708,0.4663
227,Tumor State 3,ONCOGENIC_RAPA_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.3783,0.3916
228,Tumor State 3,ONCOGENIC_RB_DN.V1_DN,0.0,0.0,0.0,0.0,0.4544,0.4619
229,Tumor State 3,ONCOGENIC_RB_DN.V1_UP,0.0,0.0,0.0,0.0,0.1131,0.1479
231,Tumor State 3,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.1843
232,Tumor State 3,ONCOGENIC_RB_P130_DN.V1_DN,0.0001,0.0,0.0003,0.0001,0.4544,0.4662
233,Tumor State 3,ONCOGENIC_RB_P130_DN.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.2011
234,Tumor State 3,ONCOGENIC_RELA_DN.V1_DN,0.0,0.0,0.0,0.0,0.1011,0.1399
235,Tumor State 3,ONCOGENIC_RELA_DN.V1_UP,0.0,0.0,0.0,0.0,0.3783,0.4106
236,Tumor State 3,ONCOGENIC_RPS14_DN.V1_DN,0.0,0.0,0.0,0.0,0.3068,0.3147
237,Tumor State 3,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.4708,0.4662
238,Tumor State 3,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0,0.0,0.0,0.0,0.4544,0.4619
239,Tumor State 3,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.1252,0.1526
241,Tumor State 3,ONCOGENIC_SNF5_DN.V1_DN,0.0,0.0,0.0,0.0,0.4708,0.4753
242,Tumor State 3,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.2606,0.2956
244,Tumor State 3,ONCOGENIC_SRC_UP.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.1895
245,Tumor State 3,ONCOGENIC_STK33_DN,0.0306,0.0448,0.0003,0.0007,0.4339,0.4243
246,Tumor State 3,ONCOGENIC_STK33_NOMO_DN,0.0036,0.0053,0.0,0.0001,0.4489,0.4507
247,Tumor State 3,ONCOGENIC_STK33_NOMO_UP,0.0,0.0,0.0,0.0,0.4489,0.4619
249,Tumor State 3,ONCOGENIC_STK33_SKM_UP,0.0001,0.0001,0.0003,0.0005,0.4691,0.4662
250,Tumor State 3,ONCOGENIC_STK33_UP,0.0,0.0,0.0,0.0,0.4544,0.4619
251,Tumor State 3,ONCOGENIC_TBK1.DF_DN,0.0056,0.0065,0.0,0.0,0.4544,0.4591
252,Tumor State 3,ONCOGENIC_TBK1.DF_UP,0.0,0.0,0.0006,0.0009,0.4544,0.4619
253,Tumor State 3,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0,0.0,0.4708,0.4663
256,Tumor State 3,ONCOGENIC_TGFB_UP.V1_UP,0.0,0.0,0.0,0.0,0.4708,0.4662
257,Tumor State 3,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.1475,0.1936
259,Tumor State 3,ONCOGENIC_WNT_UP.V1_DN,0.0052,0.0052,0.0075,0.0077,0.4708,0.4774
260,Tumor State 3,ONCOGENIC_WNT_UP.V1_UP,0.0,0.0,0.0,0.0,0.1475,0.1686
261,Tumor State 3,ONCOGENIC_YAP1_DN,0.0004,0.0006,0.0,0.0,0.2042,0.2818
262,Tumor State 3,ONCOGENIC_YAP1_UP,0.0017,0.0025,0.0116,0.0176,0.4489,0.4535
